Losartan Potassium Tablets, 100 Mg
Product Images NDC 43353-299

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Losartan Potassium Tablets, 100 Mg (NDC 43353-299). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 100mg (43353 299)

Label for Losartan Potassium Tablets 100 mg, containing 90 tablets, manufactured by Aphena Pharma Solutions - Tennessee, LLC. The label includes dosage storage instructions and a barcode. The product NDC is 43353-299-60.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure 1 (Figure1)

A line graph comparing the percentage of patients reaching a primary endpoint over a 66-month study period for Atenolol (dotted line) and Losartan Potassium (solid line). The graph indicates an adjusted risk reduction of 13%, with statistical significance (p=0.021).*

FDA Label Image

Figure 2 (Figure2)

A line graph comparing the percentage of patients with fatal/non-fatal stroke over 66 study months for Atenolol (dotted line) and Losartan Potassium (solid line). The graph shows adjusted risk reduction of 25% for Losartan Potassium with a p-value of 0.001.*

FDA Label Image

Figure 3 (Figure3)

A forest plot figure titled 'Primary Endpoint Events within Demographic Subgroups' compares Losartan and Atenolol event rates for primary composite endpoints and stroke (fatal/non-fatal). It shows patient counts, event rates (%), and hazard ratios with 95% confidence intervals across subgroups by age, gender, race, ISH, diabetes, and cardiovascular history. Symbols indicate sample size proportionality, with separate data columns for each subgroup and outcome.*

FDA Label Image

Figure 4.jpg (Figure4)

A line graph comparing the percentage of patients with an event over 48 months between Losartan Potassium and Placebo groups. The vertical axis shows % patients with event, and the horizontal axis represents time in months. The graph includes a risk reduction of 16.1% with a p-value of 0.022.*

FDA Label Image

Losartan Potassium, Usp (Structure)

Chemical structure diagram of losartan potassium, the active ingredient in Losartan potassium Tablets 100 mg. The diagram shows the molecule's atomic arrangement, including a potassium ion (K+) associated with the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.